Drug Development Biotechnology Acquisitions Drug Pricing Manufacturing Vaccine Development Corporate Governance Drug Manufacturing Novo Nordisk Pfizer Mergers and Acquisitions AstraZeneca Companies Investment Corporate Transactions Drug Sales Drug Approval Weight Loss Drugs Drug Manufacturers Research and Development Eli Lilly Market Competition Clinical Trials Pharmaceutical Companies Vaccines Market Trends Drug Companies Biopharmaceuticals GSK Competition Pharmaceutical Industry Stock Market AbbVie Product Development Vaccine Manufacturing Opioid Crisis Partnerships Vaccine Manufacturers Company Performance Generic Drugs Regeneron Pharmaceuticals Regulations Drug Shortages Amylyx Pharmaceuticals FDA Approval Drug Market Johnson & Johnson Market Analysis Corporate Strategy Bristol Myers Squibb Supply Chain Management Infant Nutrition Biosimilars Corporate Actions Sales Drug Discovery Earnings Reports Product Safety Competitors Animal Health Gene Therapy Market Revenue Manufacturers Drug Safety Biotech Merck Drug Regulation Vertex Pharmaceuticals Investments Drug Approvals Regulatory Compliance Investor Relations COVID-19 Vaccines Bayer Corporate Operations Emergency Contraception Sales Litigation Big Pharma Gene Therapy Licensing Agreements Purdue Pharma Sanofi Agriculture Obesity Drugs Biopharmaceutical Companies Nicotine Products Lawsuits Consumer Products Corporate Acquisitions Healthcare Retail Pharmacy Sales Performance Drugmakers Multinational Corporations Regulation Weight-loss Medications Corporate Finance Corporate Takeovers Opioid Epidemic Merck & Co.